Search

  • HOME
  • Search
Original Articles
13935
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy
Mi Sun Kwon, Yu Min Kim, Jin Young Kim, Jae Rock Do, Yong Koo Kang, Dong Ho Park
J Korean Ophthalmol Soc. 2024;65(7):435-441.   Published online July 15, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13877
Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration
Mi Sun Kwon, Jin Young Kim, Yu Min Kim et al.
J Korean Ophthalmol Soc. 2024;65(1):27-34.   Published online January 15, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13311
Effect of Topical Bromfenac as a Treatment of Cystoid Macular Edema Following Pars Plana Vitrectomy
Cheol-Won Moon, Dong-Geun Park, Min Sagong
J Korean Ophthalmol Soc. 2020;61(12):1467-1476.   Published online December 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13287
The Effect of a 0.1% Bromfenac Solution on Diabetic Macular Edema
Byung Su Lim, Yeon Woo Cho, Jae Yon Won
J Korean Ophthalmol Soc. 2020;61(11):1273-1278.   Published online November 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
The Effect of Anti-inflammatory Agents on the Permeability of Trabecular Meshwork Cell Monolayers.
Hye Ri Kang, Jung Hoon Lee, Jae Woo Kim
J Korean Ophthalmol Soc. 2017;58(10):1155-1159.   Published online October 15, 2017
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2025 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next